Chart of Day: Could ACADIA Pharmaceuticals (ACAD) see a Buyout Offer?

The buyout rumors are swirling.  Pfizer (FPE), Biogen (BIIB) and Teva Pharmaceuticals (TEVA) are all reportedly interested in Parkinson’s disease Psychosis (PDP) drug stock, ACADIA Pharmaceuticals (ACAD).  Analysts believe ACAD could see at least a $6 billion buyout offer after the FDA approved its PDP drug that could help up to 40% of all Parkinson’s…

Details